Nureca Ltd

Thu 22/10/2026,15:51:9 | NSE : NURECA

₹333.354.45 (1.35%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 335.00

Previous Close

₹ 328.90

Volume

9735

Mkt Cap ( ₹ Cr)

₹ 333.36

High

₹ 345.30

Low

₹ 328.00

52 Week High

₹ 376.00

52 Week Low

₹ 204.00

Book Value Per Share

₹ 184.28

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Nureca Ltd

Your Vote -

Buy

35.90%

Hold

3.42%

Sell

60.68%

35.90%

117 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Nureca Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Nureca - Press Release

    21 Oct 2026, 2:41PM Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled ""Nureca records highest quarterly revenue in last 2
  • Nureca - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    21 Oct 2026, 2:38PM Nureca records highest quarterly revenue in last 20 quarters ;Q2 revenue rises 55% to Rs. 58.53 crore .
  • Nureca - Press Release

    21 Oct 2026, 2:35PM Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled ""Nureca records highest quarterly revenue in last 2
  • Nureca - Press Release

    21 Oct 2026, 2:32PM Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled ""Nureca records highest quarterly revenue in last 2
  • Nureca - Press Release

    21 Oct 2026, 2:26PM Nureca Limited has informed the Exchange regarding a press release dated October 21, 2026, titled ""Nureca records highest quarterly revenue in last 2
  • Nureca - Outcome of Board Meeting

    21 Oct 2026, 1:56PM Nureca Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
  • Nureca - Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September,2026

    21 Oct 2026, 1:54PM Un-audited Financial results for the quarter and half year ended 30th September,2026
  • Nureca has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    18 Oct 2026, 7:00AM As of September 2026, 70.68% is owned by Indian Promoters and 29.32% by Public. <p align=justify> Top two Promoters holding highest number of shares o
  • Nureca - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Req

    17 Oct 2026, 6:50PM Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Nureca - General Updates

    17 Oct 2026, 6:44PM Nureca Limited has informed the Exchange about General Updates
  • Nureca - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Oct 2026, 11:45AM Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants ) Regulations ,2018.
  • Nureca - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    15 Oct 2026, 11:33AM Nureca Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Nureca - Board Meeting Intimation for Considering And Approving, Inter-Alia, The Un-Audited Financial Results (Standalone And

    14 Oct 2026, 6:26PM Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2026 ,inter alia, to consider and approve i
  • Nureca - Updates

    1 Oct 2026, 11:52AM Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider
  • Nureca - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulati

    1 Oct 2026, 11:54AM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (\PIT Regulations\)
  • Nureca - Updates

    30 Sep 2026, 12:14PM Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider
  • Nureca - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulati

    30 Sep 2026, 12:17PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (\PIT Regulations\)
  • Nureca - Trading Window

    29 Sep 2026, 4:14PM Nureca Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Nureca - Updates

    29 Sep 2026, 12:27PM Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider
  • Nureca - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulati

    29 Sep 2026, 12:33PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (\PIT Regulations\)
  • Nureca - Updates

    28 Sep 2026, 11:37AM Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider
  • Nureca - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulati

    28 Sep 2026, 11:39AM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (\PIT Regulations\)
  • Nureca - Updates

    26 Sep 2026, 9:56AM Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider
  • Nureca - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulati

    26 Sep 2026, 9:58AM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (\PIT Regulations\)
  • Nureca - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulati

    25 Sep 2026, 9:33AM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulations ,2015 (\PIT Regulations\)
  • Nureca - Updates

    25 Sep 2026, 9:30AM Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider
  • Nureca - Updates

    10 Sep 2026, 4:02PM Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider
  • Nureca - \Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulat

    10 Sep 2026, 4:01PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations).
  • Nureca - Updates

    9 Sep 2026, 12:43PM Nureca Limited has informed the Exchange regarding ''Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Inside
  • Nureca - 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regula

    9 Sep 2026, 12:49PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
  • Nureca - 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regula

    9 Sep 2026, 12:49PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
  • Nureca - 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regula

    9 Sep 2026, 12:49PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
  • Nureca - 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regula

    9 Sep 2026, 12:49PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
  • Nureca - 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regula

    9 Sep 2026, 12:49PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
  • Nureca - 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regula

    9 Sep 2026, 12:49PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
  • Nureca - 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regula

    9 Sep 2026, 12:49PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
  • Nureca - 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regula

    9 Sep 2026, 12:49PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
  • Nureca - Updates

    29 Aug 2026, 4:16PM Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider
  • Nureca - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulati

    29 Aug 2026, 4:21PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulations ,2015 (\PIT Regulations \)
  • Nureca - Action(s) taken or orders passed

    21 Aug 2026, 12:58PM Nureca Limited has informed the Exchange about Action(s) taken or orders passed
  • Nureca - Updates

    11 Aug 2026, 5:30PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations ).'.
  • Nureca - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulati

    11 Aug 2026, 5:38PM Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading )Regulations ,2015 (PIT Regulations )
  • Nureca - Additional Details Required For Corporate Announcement Under Regulation 30(4) Of The SEBI (Listing Obligations And D

    10 Aug 2026, 6:03PM Additional details required for Corporate Announcement under Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation
  • Nureca - Pendency Of Litigation(S)/Dispute(S) Or The Outcome Impacting The Company.

    7 Aug 2026, 12:10PM Pendency of Litigation(s)/disput(s) or the outcome impacting the Company.
  • Nureca - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    7 Aug 2026, 11:44AM Nureca Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
  • Nureca - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Jul 2026, 7:20PM Scrutinizer Report and Voting Results for the 10th Annual General Meeting
  • Nureca - Shareholders meeting

    28 Jul 2026, 7:16PM Nureca Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 28, 2026. Further, the company has informe
  • Nureca - Shareholder Meeting / Postal Ballot-Outcome of AGM

    28 Jul 2026, 7:14PM Outcome and Proceedings of the 10th Annual General Meeting.
  • Nureca - Shareholders meeting

    28 Jul 2026, 7:08PM Nureca Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 28, 2026
  • Nureca - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Jul 2026, 7:20PM Scrutinizer Report and Voting Results for the 10th Annual General Meeting
  • Nureca - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Jul 2026, 7:20PM Scrutinizer Report and Voting Results for the 10th Annual General Meeting
  • Nureca - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Jul 2026, 7:20PM Scrutinizer Report and Voting Results for the 10th Annual General Meeting
  • Nureca - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Jul 2026, 7:20PM Scrutinizer Report and Voting Results for the 10th Annual General Meeting
  • Nureca - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Jul 2026, 7:20PM Scrutinizer Report and Voting Results for the 10th Annual General Meeting
  • Nureca - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Jul 2026, 7:20PM Scrutinizer Report and Voting Results for the 10th Annual General Meeting
  • Nureca - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    28 Jul 2026, 7:20PM Scrutinizer Report and Voting Results for the 10th Annual General Meeting
  • Nureca hit 5% upper circuit

    24 Jun 2021 , 2:47PM Hornbill Orchid India picks up 2% stake in Nureca

Key fundamentals

Evaluate the intrinsic value of Nureca Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 177.827 194.002 193.261 195.263 203.743
Liabilities 177.827 194.002 193.261 195.263 203.743
Equity 9.542 10 10 10 10
Gross Profit -2.606 -9.732 -11.131 -15.39 55.773
Net Profit 0.297 -0.668 -2.442 -8.422 45.309
Cash From Operating Activities 0.319 -18.548 -2.997 12.051 1.827
NPM(%) 0.2 -0.58 -2.58 -7.52 17.73
Revenue 147.21 114.64 94.521 111.899 255.549
Expenses 149.816 124.372 105.652 127.289 199.776
ROE(%) 0.16 -0.36 -1.32 -4.57 24.58

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
24 Feb 2022 3 30 0 1489.5
21 Sep 2021 2 20 0 1546.25

Peers

Other companies within the same industry or sector that are comparable to Nureca Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Procter and Gamble Hygiene and Healthcare Ltd 6800.00 -1.48 27.92 1080.92 2638.57 3.75
Godrej Industries Ltd 951.90 -2.49 27.28 11215.44 3682.73 0.00
Colgate-Palmolive (India) Ltd 1685.00 -2.03 33.65 9057.60 4872.72 2.85
Sacheerome Ltd 425.00 -0.12 33.44 745.01 127.12 0.00

Company Info

The Company was incorporated as `Nureca Private Limited', as a private limited company, under the Companies Act, 2013 on November 2, 2016 and a certificate of incorporation was issued by Registrar of Companies, Central Registration Centre, at Delhi. The registered office of the Company was changed from Delhi to Mumbai, Maharashtra, pursuant to certificate of registration of regional director order dated January 8, 2019 for change of state issued by the RoC with effect from February 8, 2019. Upon to conversion into a public limited company pursuant to a special resolution passed in the extra ordinary general meeting of the shareholders of the Company held on June 19, 2020, the name of the Company was changed to the present name `Nureca Limited' and a fresh certificate of incorporation was issued by the RoC on July 8, 2020.The Company became a wholly owned Subsidiary of Nectar Biopharma Private Limited on August 16, 2018. Pursuant to the Scheme of Arrangement approved by the NCLT, Special Bench, Mumbai vide its order dated April 29, 2020, the Specified Undertaking (as defined in the Scheme of Arrangement) was demerged from Nectar Biopharma Private Limited and vested into the Company. Consequently, 1 equity share of face value Rs.10 each of the Company was issued to each shareholders of Nectar Biopharma Private Limited for every 1 equity shares of face value Rs.10 each, held by them in Nectar Biopharma Private Limited as on the record date, i.e. June 9, 2020.Major Events and Milestones :2016- Online launch of Dr. Trust Brand.2017- Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.- Started three flex centres in Punjab, Karnataka and Uttar Pradesh.2018- The Company became the wholly owned subsidiary of Nectar Biopharma Private Limited.- Added three flex centres in Chandigarh, Telangana and Maharashtra.- Secured warehouse drug license.2020- Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the Company pursuant to the Scheme of Arrangement.2024-Nureca Ltd. has entered into a Distribution Agreement, making its products available on a leading quick commerce platform in India.2025-Nureca Ltd. expands Quick Commerce Reach with Dr Trust products now available on Swiggy Instamart.

The Company was incorporated as `Nureca Private Limited', as a private limited company, under the Companies Act, 2013 on November 2, 2016 and a certificate of incorporation was issued by Registrar of Companies, Central Registration Centre, at Delhi. The registered office of the Company was changed from Delhi to Mumbai, Maharashtra, pursuant to certificate of registration of regional director order dated January 8, 2019 for change of state issued by the RoC with effect from February 8, 2019. Upon to conversion into a public limited company pursuant to a special resolution passed in the extra ordinary general meeting of the shareholders of the Company held on June 19, 2020, the name of the Company was changed to the present name `Nureca Limited' and a fresh certificate of incorporation was issued by the RoC on July 8, 2020.The Company became a wholly owned Subsidiary of Nectar Biopharma Private Limited on August 16, 2018. Pursuant to the Scheme of Arrangement approved by the NCLT, Special Bench, Mumbai vide its order dated April 29, 2020, the Specified Undertaking (as defined in the Scheme of Arrangement) was demerged from Nectar Biopharma Private Limited and vested into the Company. Consequently, 1 equity share of face value Rs.10 each of the Company was issued to each shareholders of Nectar Biopharma Private Limited for every 1 equity shares of face value Rs.10 each, held by them in Nectar Biopharma Private Limited as on the record date, i.e. June 9, 2020.Major Events and Milestones :2016- Online launch of Dr. Trust Brand.2017- Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.- Started three flex centres in Punjab, Karnataka and Uttar Pradesh.2018- The Company became the wholly owned subsidiary of Nectar Biopharma Private Limited.- Added three flex centres in Chandigarh, Telangana and Maharashtra.- Secured warehouse drug license.2020- Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the Company pursuant to the Scheme of Arrangement.2024-Nureca Ltd. has entered into a Distribution Agreement, making its products available on a leading quick commerce platform in India.2025-Nureca Ltd. expands Quick Commerce Reach with Dr Trust products now available on Swiggy Instamart.

Parent Organisation

Nureca Ltd.

Founded

02/11/2016

Managing Director

Mr.Saurabh Goyal

NSE Symbol

NURECABE

FAQ